We are committed to revolutionizing the treatment of severe refractory asthma by providing a therapy that surpasses the current standard of care.

Our goal is to treat severe refractory asthma by using a patient's own genetically modified macrophages in which we eliminate the gene responsible for underlying chronic lung modifications.

This personalized therapy aims to provide long-lasting control over airway inflammation and minimize the need for systemic medications.

We are dedicated to providing safe, effective, and targeted treatment for severe refractory asthma. Our approach not only addresses the underlying cause of the condition by reversing its inflammatory process but also focuses on restoring lung function.